Literature DB >> 21877119

B7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors.

Tomonori Kaifu1, Bertrand Escalière, Louis N Gastinel, Eric Vivier, Myriam Baratin.   

Abstract

Natural killer (NK) cells are lymphocytes of the innate immune system that sense target cells through a panel of activating and inhibitory receptors. Together with NKG2D, the natural cytotoxicity receptors (NCRs) are major activating receptors involved in tumor cell detection. Although numerous NKG2D ligands have been identified, characterization of the molecules interacting with the NCRs is still incomplete. The identification of B7-H6 as a counter structure of the NCR NKp30 shed light on the molecular basis of NK cell immunosurveillance. We review here the current knowledge on NKp30 and B7-H6, and we discuss their potential role in anti-tumor immunity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21877119     DOI: 10.1007/s00018-011-0802-7

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  51 in total

1.  A new member of the Ig superfamily and a V-ATPase G subunit are among the predicted products of novel genes close to the TNF locus in the human MHC.

Authors:  M J Neville; R D Campbell
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

2.  Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis.

Authors:  Roberta Castriconi; Alessandra Dondero; Raffaella Augugliaro; Claudia Cantoni; Barbara Carnemolla; Angela Rita Sementa; Francesca Negri; Romana Conte; Maria Valeria Corrias; Lorenzo Moretta; Alessandro Moretta; Cristina Bottino
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

3.  Natural killer cell signaling pathways.

Authors:  Eric Vivier; Jacques A Nunès; Frédéric Vély
Journal:  Science       Date:  2004-11-26       Impact factor: 47.728

4.  Identification and hormonal regulation of a novel form of NKp30 in human endometrial epithelium.

Authors:  Anna P Ponnampalam; Caroline E Gargett; Peter A W Rogers
Journal:  Eur J Immunol       Date:  2008-01       Impact factor: 5.532

5.  NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor.

Authors:  Massimo Vitale; Mariella Della Chiesa; Simona Carlomagno; Daniela Pende; Maurizio Aricò; Lorenzo Moretta; Alessandro Moretta
Journal:  Blood       Date:  2005-03-22       Impact factor: 22.113

6.  Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus.

Authors:  Tal I Arnon; Hagit Achdout; Ofer Levi; Gal Markel; Nivin Saleh; Gil Katz; Roi Gazit; Tsufit Gonen-Gross; Jacob Hanna; Efrat Nahari; Angel Porgador; Alik Honigman; Bodo Plachter; Dror Mevorach; Dana G Wolf; Ofer Mandelboim
Journal:  Nat Immunol       Date:  2005-04-10       Impact factor: 25.606

7.  Differential NKp30 inducibility in chimpanzee NK cells and conserved NK cell phenotype and function in long-term HIV-1-infected animals.

Authors:  Erik Rutjens; Stefania Mazza; Roberto Biassoni; Gerrit Koopman; Luana Radic; Manuela Fogli; Paola Costa; Maria Cristina Mingari; Lorenzo Moretta; Jonathan Heeney; Andrea De Maria
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

8.  Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D.

Authors:  Noam Stern-Ginossar; Chamutal Gur; Moshe Biton; Elad Horwitz; Moran Elboim; Noa Stanietsky; Michal Mandelboim; Ofer Mandelboim
Journal:  Nat Immunol       Date:  2008-09       Impact factor: 25.606

9.  The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans.

Authors:  Cameron S Brandt; Myriam Baratin; Eugene C Yi; Jacob Kennedy; Zeren Gao; Brian Fox; Betty Haldeman; Craig D Ostrander; Tomonori Kaifu; Christian Chabannon; Alessandro Moretta; Robert West; Wenfeng Xu; Eric Vivier; Steven D Levin
Journal:  J Exp Med       Date:  2009-06-15       Impact factor: 14.307

10.  Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress.

Authors:  Timothy J Nice; Laurent Coscoy; David H Raulet
Journal:  J Exp Med       Date:  2009-01-26       Impact factor: 14.307

View more
  43 in total

1.  When killers become helpers.

Authors:  Umesh S Deshmukh; Harini Bagavant
Journal:  Sci Transl Med       Date:  2013-07-24       Impact factor: 17.956

2.  Homo-oligomerization of the activating natural killer cell receptor NKp30 ectodomain increases its binding affinity for cellular ligands.

Authors:  Julia Herrmann; Hannah Berberich; Jessica Hartmann; Steffen Beyer; Karen Davies; Joachim Koch
Journal:  J Biol Chem       Date:  2013-11-25       Impact factor: 5.157

Review 3.  Recognition of tumors by the innate immune system and natural killer cells.

Authors:  Assaf Marcus; Benjamin G Gowen; Thornton W Thompson; Alexandre Iannello; Michele Ardolino; Weiwen Deng; Lin Wang; Nataliya Shifrin; David H Raulet
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

4.  B7-H6 expression in non-small cell lung cancers.

Authors:  Xiuqin Zhang; Guangbo Zhang; Yan Qin; Ruizhen Bai; Jianan Huang
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

Review 5.  Natural killer cell cytotoxicity and its regulation by inhibitory receptors.

Authors:  Santosh Kumar
Journal:  Immunology       Date:  2018-04-11       Impact factor: 7.397

6.  Clinical significance of novel costimulatory molecule B7-H6 in human breast cancer.

Authors:  Jing Sun; Hong Tao; Xiaoning Li; Lu Wang; Jie Yang; Pingping Wu; Yaqin Zhang; Yundi Guo
Journal:  Oncol Lett       Date:  2017-06-19       Impact factor: 2.967

7.  B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape.

Authors:  Silvia Pesce; Giovanna Tabellini; Claudia Cantoni; Ornella Patrizi; Daniela Coltrini; Fabio Rampinelli; Jessica Matta; Eric Vivier; Alessandro Moretta; Silvia Parolini; Emanuela Marcenaro
Journal:  Oncoimmunology       Date:  2015-01-22       Impact factor: 8.110

Review 8.  Targeting the B7 family of co-stimulatory molecules: successes and challenges.

Authors:  Joseph R Podojil; Stephen D Miller
Journal:  BioDrugs       Date:  2013-02       Impact factor: 5.807

9.  Comprehensive molecular profiling of the B7 family of immune-regulatory ligands in breast cancer.

Authors:  Zhenyu Xu; Jing Shen; Maggie Haitian Wang; Tao Yi; Yangyang Yu; Yinxin Zhu; Bo Chen; Jianping Chen; Longfei Li; Minxing Li; Jian Zuo; Hui Jiang; Dexi Zhou; Jiajie Luan; Zhangang Xiao
Journal:  Oncoimmunology       Date:  2016-07-11       Impact factor: 8.110

10.  The proto-oncogene Myc drives expression of the NK cell-activating NKp30 ligand B7-H6 in tumor cells.

Authors:  Sonja Textor; Felicitas Bossler; Kai-Oliver Henrich; Moritz Gartlgruber; Julia Pollmann; Nathalie Fiegler; Annette Arnold; Frank Westermann; Nina Waldburger; Kai Breuhahn; Sven Golfier; Mathias Witzens-Harig; Adelheid Cerwenka
Journal:  Oncoimmunology       Date:  2016-07-28       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.